Skip to main content

Medrada, Inc.’s novel fluorodeoxyglucose (FDG) Intego™ PET Infusion System, an infusion system for positron emission tomography/computed tomography (PET/CT) imaging procedures, has been granted 510(k) clearance by the United States Food and Drug Administration.

The Intego PET Infusion System is an automated system that controls and delivers FDG to the patient. The FDG is extracted from a multi-dose vial and delivered directly to the patient, virtually eliminating manual handling, preparation, and radiation exposure to the technologist. The Intego System has an on-demand dosing system so that the precise dose of FDG can be delivered at any time.

The Intego PET Infusion System is the first infusion system available in the United States that automates the delivery process of FDG.

Recommended Articles


Nutritional Needs during Cancer Treatment

Expert insight into eating well during cancer treatment

Image placeholder title

Understanding Cancer Treatment: An Overview

Understand cancer treatment and its side effects from surgery to immunotherapy to complementary and integrative medicine

Image placeholder title

Newly Diagnosed With Cancer - Start Here!

Newly diagnosed with cancer? Start here to move forward from diagnosis to treatment and survivorship.